Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?

Abstract Background Prevention of chronic pain relies on accurate detection of at-risk patients. Screening tools have been validated mainly in (sub) acute spinal pain and the need of more generic tools is high. We assessed the validity of the French version of the short Örebro Musculoskeletal Pain S...

Full description

Bibliographic Details
Main Authors: Natalya Korogod, Arnaud Steyaert, Olivier Nonclercq, Emmanuelle Opsommer, Anne Berquin
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12891-021-04944-9
_version_ 1818774339014623232
author Natalya Korogod
Arnaud Steyaert
Olivier Nonclercq
Emmanuelle Opsommer
Anne Berquin
author_facet Natalya Korogod
Arnaud Steyaert
Olivier Nonclercq
Emmanuelle Opsommer
Anne Berquin
author_sort Natalya Korogod
collection DOAJ
description Abstract Background Prevention of chronic pain relies on accurate detection of at-risk patients. Screening tools have been validated mainly in (sub) acute spinal pain and the need of more generic tools is high. We assessed the validity of the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) in patients with a large range of pain duration and localization. Methods First, we re-analyzed data from a 6-month longitudinal study of 73 patients with (sub) acute spinal pain consulting in secondary line settings. Secondly, we performed a new 12-month longitudinal study of 542 primary care patients with (sub) acute and chronic pain in different localizations (spinal, limbs, “non-musculoskeletal”). The area under the receiver operating characteristic curve and cutoff scores were computed and compared for different subpopulations and ÖMPSQ subscores. Results Data from patients suffering from (sub) acute and chronic spinal pain consulting in both primary and secondary care settings confirmed the validity of the short French ÖMPSQ version and its subsets. In the primary care cohort, the performance of the questionnaire and its psychosocial subscore was variable but at least “fair” in most populations ((sub) acute and chronic, spinal and limb pain). Cutoff scores showed quite large variability depending on the outcome and the subpopulation considered. Conclusions These results confirm the usefulness of the short French ÖMPSQ for prediction of the evolution of (sub) acute and chronic patients with spinal and limb pain, whatever its duration. However, increasing population heterogeneity results in slightly worse predictive performance and largely variable cutoff scores. Consequently, it might be difficult to choose universal cutoff scores and other criteria, such as patients’ values and the available resources for patient management, should be taken into account.
first_indexed 2024-12-18T10:39:34Z
format Article
id doaj.art-d600d43617664fdeb33aff136e51a183
institution Directory Open Access Journal
issn 1471-2474
language English
last_indexed 2024-12-18T10:39:34Z
publishDate 2022-04-01
publisher BMC
record_format Article
series BMC Musculoskeletal Disorders
spelling doaj.art-d600d43617664fdeb33aff136e51a1832022-12-21T21:10:40ZengBMCBMC Musculoskeletal Disorders1471-24742022-04-0123111510.1186/s12891-021-04944-9Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?Natalya Korogod0Arnaud Steyaert1Olivier Nonclercq2Emmanuelle Opsommer3Anne Berquin4School of Health Sciences (HESAV), University of Applied Sciences and Arts Western Switzerland (HES-SO)Department of Anesthesiology, Cliniques universitaires Saint-LucGrand Hôpital de Charleroi, Service de Médecine Physique et RéadaptationSchool of Health Sciences (HESAV), University of Applied Sciences and Arts Western Switzerland (HES-SO)Institute of Neuroscience, Université Catholique de LouvainAbstract Background Prevention of chronic pain relies on accurate detection of at-risk patients. Screening tools have been validated mainly in (sub) acute spinal pain and the need of more generic tools is high. We assessed the validity of the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) in patients with a large range of pain duration and localization. Methods First, we re-analyzed data from a 6-month longitudinal study of 73 patients with (sub) acute spinal pain consulting in secondary line settings. Secondly, we performed a new 12-month longitudinal study of 542 primary care patients with (sub) acute and chronic pain in different localizations (spinal, limbs, “non-musculoskeletal”). The area under the receiver operating characteristic curve and cutoff scores were computed and compared for different subpopulations and ÖMPSQ subscores. Results Data from patients suffering from (sub) acute and chronic spinal pain consulting in both primary and secondary care settings confirmed the validity of the short French ÖMPSQ version and its subsets. In the primary care cohort, the performance of the questionnaire and its psychosocial subscore was variable but at least “fair” in most populations ((sub) acute and chronic, spinal and limb pain). Cutoff scores showed quite large variability depending on the outcome and the subpopulation considered. Conclusions These results confirm the usefulness of the short French ÖMPSQ for prediction of the evolution of (sub) acute and chronic patients with spinal and limb pain, whatever its duration. However, increasing population heterogeneity results in slightly worse predictive performance and largely variable cutoff scores. Consequently, it might be difficult to choose universal cutoff scores and other criteria, such as patients’ values and the available resources for patient management, should be taken into account.https://doi.org/10.1186/s12891-021-04944-9Low back painSecondary preventionÖrebro Musculoskeletal Pain Screening QuestionnairePsychosocialScreening
spellingShingle Natalya Korogod
Arnaud Steyaert
Olivier Nonclercq
Emmanuelle Opsommer
Anne Berquin
Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
BMC Musculoskeletal Disorders
Low back pain
Secondary prevention
Örebro Musculoskeletal Pain Screening Questionnaire
Psychosocial
Screening
title Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_full Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_fullStr Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_full_unstemmed Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_short Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_sort can the french version of the short orebro musculoskeletal pain screening questionnaire or its subsets predict the evolution of patients with acute sub acute and chronic pain
topic Low back pain
Secondary prevention
Örebro Musculoskeletal Pain Screening Questionnaire
Psychosocial
Screening
url https://doi.org/10.1186/s12891-021-04944-9
work_keys_str_mv AT natalyakorogod canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain
AT arnaudsteyaert canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain
AT oliviernonclercq canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain
AT emmanuelleopsommer canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain
AT anneberquin canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain